GREGORY JULIA P — SEC insider filings

SEC reporting owner CIK 1226675. 18 insider filings on record with FilingPulse; latest filed 2026-10-14.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2021-05-07 to 2026-10-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Director4—1 leg · 12,000 sh · $1,500,0008
Nurix Therapeutics, Inc. (NRIX)Director8—1 leg · 22,583 sh · $528,52810
Biohaven Ltd. (BHVN)Director61 leg · 9,523 sh · $99,992—18

Insider filings — GREGORY JULIA P

FiledFormIssuerReported transactionsSource
2026-10-144Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 22,583 @ $1.86 · Sale (S): 22,583 @ $23.40 · Option exercise (M): 22,583 (derivative) @ $0EDGAR
2026-05-154Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 31,250 (derivative) @ $0EDGAR
2026-04-304Biohaven Ltd. (BHVN)Grant/award (A): 68,693 (derivative) @ $0EDGAR
2025-09-174Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 10,750 @ $1.86 · Option exercise (M): 10,750 (derivative) @ $0EDGAR
2025-05-194Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2025-05-074Biohaven Ltd. (BHVN)Grant/award (A): 31,716 (derivative) @ $0EDGAR
2024-05-204Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2024-05-024Biohaven Ltd. (BHVN)Grant/award (A): 16,592 (derivative) @ $0EDGAR
2023-05-044Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-05-044Biohaven Ltd. (BHVN)Grant/award (A): 52,906 (derivative) @ $0EDGAR
2022-10-264Biohaven Ltd. (BHVN)Purchase (P): 9,523 @ $10.50EDGAR
2022-10-054Biohaven Ltd. (BHVN)Option exercise (M): 4,119 @ $4.84 · Option exercise (M): 5,998 @ $3.56 · Option exercise (M): 9,000 @ $2.33 · Option exercise (M): 9,000 @ $3.06 · Tax withholding (F): 11,975 @ $7.50 · Other (J): 4,119 (derivative) · +8 moreEDGAR
2022-10-034Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Disposition to issuer (D): 8,239 (derivative) · Disposition to issuer (D): 11,996 (derivative) · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 18,000 (derivative)EDGAR
2022-05-064Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2022-04-294Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Grant/award (A): 8,239 (derivative) @ $0EDGAR
2021-12-224Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Option exercise (M): 12,000 @ $23.63 · Sale (S): 12,000 @ $125 · Option exercise (M): 12,000 (derivative) @ $0EDGAR
2021-05-244Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2021-05-074Biohaven Pharmaceutical Holding Co Ltd. (BHVN)Grant/award (A): 11,996 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-05-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1226675 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs